Globenewswire·2026-03-04 17:30Core Viewpoint - Sanofi has filed an amendment to its "Document d'Enregistrement Universel" which includes the Annual Financial Report and updates on corporate governance as per French law [1]. Group 1: Company Information - Sanofi is an R&D driven, AI-powered biopharma company focused on improving lives and fostering growth through innovative medicines and vaccines [3]. - The company aims to address urgent healthcare, environmental, and societal challenges, guided by a commitment to scientific progress [3]. - Sanofi is publicly listed on EURONEXT under the ticker SAN and on NASDAQ as SNY [3]. Group 2: Regulatory Filing - The amendment to the Annual Financial Report has been submitted to the French market regulator, Autorité des marchés financiers (AMF) [1]. - The updated report includes significant additions related to corporate governance [1]. Group 3: Accessibility of Information - The amended document is accessible on Sanofi's official website and the AMF's website [2].